Best Lawyers has once again recognized Schlichter Bogard in its 2027 Best Law Firms national and regional rankings across multiple practice areas. Best Lawyers continues to rank Schlichter Bogard among top firms across all of the Firm’s practices areas. This year, the Firm received national and/or regional recognition from Best Lawyers for its work in Railroad Law, Mass Tort/Class Action, Personal Injury, Product Liability, and Privacy and Data Security Law.
Ryan Weiss
Michigan
As seen in:
Apple Podcasts,
Nature,
Frontiers,
PNAS,
Maxim,
JD Supra,
Cleveland Scene,
The Journal of Clinical Investigation,
The Argus-Press,
The Villages Daily Sun
and
Former newspaper editor
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Ryan Weiss
Announcing the Release of Schlichter Bogard’s Fall 2026 Railroad Injury Newsletter
Schlichter Bogard is pleased to announce the release of our Fall 2026 Railroad Injury newsletter exclusively covering railroad-related topics. Featured in this month’s issue: Learn the common mistakes that can undermine an FELA claim and the critical steps injured railroad workers should take immediately after an on-the-job injury. Get an inside look at how railroads investigate workplace injuries and why understanding the process can help protect your rights.
USA Today Highlights Schlichter Bogard Litigation Seeking to Lower Healthcare Costs for Employees
USA Today recently highlighted the impact of litigation brought by Schlichter Bogard on behalf of employees seeking to reduce excessive healthcare-related costs. The article discusses rising healthcare expenses facing American workers and notes efforts to improve transparency and accountability in the administration of employee benefit plans.
Health Data Privacy Lawsuit Against Humana Brought on Behalf of Plaintiffs Represented by Schlichter Bogard Will Proceed
As reported by VitalLaw, a federal court has allowed claims to proceed in a lawsuit alleging that Humana improperly disclosed individuals’ health information through tracking technologies embedded on its websites and online platforms. The lawsuit, brought on behalf of plaintiffs represented by Schlichter Bogard, alleges that tracking tools transmitted users’ sensitive health-related information to third parties without the authorization required by law.
Schlichter Bogard Named “Legal Lion of the Week” Following Landmark Eleventh Circuit ERISA Victory
Law360 has recognized Schlichter Bogard as “Legal Lion of the Week” following a significant victory before the U.S. Court of Appeals for the Eleventh Circuit. The recognition stems from the Firm’s role in securing a decision overturning a decades-old Eleventh Circuit precedent that required participants to exhaust administrative remedies before pursuing certain statutory claims under the Employee Retirement Income Security Act (ERISA).
U.S. Court of Appeals for the Eleventh Circuit Rules That Class Action Brought by Schlichter Bogard on Behalf of Current and Former Inland Fresh Workers May Proceed, Overturning Circuit Precedent
As reported by Law360, the U.S. Court of Appeals for the Eleventh Circuit has revived a class action brought on behalf of current and former Inland Fresh workers represented by Schlichter Bogard and, in the process, overturned longstanding precedent. The case involves allegations that fiduciaries of Inland Fresh’s employee stock ownership plan breached their duties to current and former employee plan participants.
Judge Rules Apple Will Face Trial in Biometric Privacy Lawsuit Brought by Schlichter Bogard on Behalf of Illinois Users
As reported by Law360, a federal judge has ruled that Apple must face a jury trial over claims that it unlawfully collected and possessed Illinois users’ faceprints without the notice and consent required by the Illinois Biometric Information Privacy Act (BIPA).
A non-canonical EZH2/TRIM28 epigenetic axis drives heparan sulfate remodeling and melanoma metastasis
Abstract Melanoma progression is driven not only by oncogenic alterations but also by epigenetic programs that remodel the tumor microenvironment. Heparan sulfate (HS) proteoglycans are extracellular matrix components that control growth factor signaling and cell-matrix interactions, yet how chromatin-associated factors regulate HS remodeling in cancer remains ill-defined. Here, we identify the histone methyltransferase EZH2 as a regulator of HS biosynthesis in melanoma.
Charter Communications 401(k) Forfeiture Lawsuit Brought by Schlichter Bogard Will Proceed
As reported by Law360, a federal judge has allowed key claims to proceed in a lawsuit brought on behalf of participants in the Charter Communications 401(k) Plan alleging violations of the Employee Retirement Income Security Act (ERISA). The lawsuit alleges that Charter improperly used forfeited plan assets and breached its fiduciary duties under ERISA.
Schlichter Bogard Secures Final Approval of $13.4 Million Liberty Mutual Settlement
As reported by Law360, a Massachusetts federal court has granted final approval of a $13.4 million settlement obtained by Schlichter Bogard on behalf of participants in the Liberty Mutual 401(k) Plan. The lawsuit, originally filed by Schlichter Bogard in 2020, alleged that Liberty Mutual and its fiduciaries failed to adequately monitor recordkeeping expenses and retained investments that harmed participants’ retirement savings.
Jerry Schlichter Quoted in Financial Times Article Examining Private Capital’s Growing Role in the Insurance Industry
Schlichter Bogard Co-Managing Partner Jerry Schlichter was quoted in a recent Financial Times article examining the increasing role of private capital firms in the insurance industry and the potential risks posed by affiliated investments and other private-market strategies.
Schlichter Bogard Recognized by Pope Leo XIV and Cardinal Pedro Barreto for Work in 19-Year Lead Poisoning Case on Behalf of Peruvian Children and Young Adults
As reported by The Guardian, Peruvian Cardinal Pedro Barreto has recognized Schlichter Bogard following the Firm’s $150 million settlement on behalf of 1,373 Peruvian children and young adults who alleged injuries resulting from environmental contamination near the La Oroya smelter.
Schlichter Bogard Obtains Proposed $48 Million Settlement for Retirement Plan Participants in ADP 401(k) Litigation
Various media outlets have reported on a proposed $48 million settlement in litigation brought by Schlichter Bogard on behalf of participants in the ADP TotalSource Retirement Savings Plan. The lawsuit alleged that ADP breached its fiduciary duties under ERISA by retaining underperforming investment options and causing the plan to pay excessive fees. The proposed settlement resolves claims brought on behalf of participants and beneficiaries in the approximately $7.8 billion retirement plan.
The Times of London Reports on Biometric Data Privacy Action Against Apple Brought by Schlichter Bogard
The Times of London has reported on a biometric data privacy lawsuit against Apple brought by Schlichter Bogard on behalf of Illinois citizens. As The Times reported, the lawsuit alleges that Apple’s facial-recognition technology creates biologically unique “faceprints” of individuals, including children, who appear in users’ photo libraries, and stores those faceprints on cloud-based servers, without informing users or obtaining user consent.
MPA Names Roath CSO; Camara Promoted to Director of Membership
LANSING – The Michigan Pharmacists Association (MPA) announces the promotions of Eric Roath to chief strategy officer and Sona Camara to director of membership. Roath’s dedication to the mission and vision of the association and his diverse experience and training positions him well to assume this new role.
Health Data Privacy Lawsuit Against Cigna Brought on Behalf of Plaintiffs Represented by Schlichter Bogard Will Proceed
As reported by Law360, a federal judge in Pennsylvania has allowed a proposed class action led by Schlichter Bogard against Cigna to proceed, rejecting the company’s efforts to dismiss most claims alleging that insureds’ protected health information was unlawfully disclosed through tracking technology embedded in Cigna’s online portals.
Jerry Schlichter Interviewed About the Evolving Landscape of Employee Benefits Litigation
Schlichter Bogard Co-Managing Partner Jerry Schlichter was featured in a Law360 interview discussing the evolution of ERISA litigation, recent developments in retirement plan cases, and the fiduciary obligations owed to workers and retirees.
Announcing the Release of Schlichter Bogard’s Summer 2026 Railroad Injury Newsletter
Schlichter Bogard is pleased to announce the release of our Summer 2026 Railroad Injury newsletter exclusively covering railroad-related topics. Featured in this month’s issue: A closer look at federal safety data reveals that despite improved statistics, railroad work remains dangerous and preventable injuries continue to impact workers every day.
Schlichter Bogard Reaches Landmark $150 Million Settlement in Doe Run Lead Poisoning Litigation
As reported by several media outlets, Schlichter Bogard has secured a landmark $150 million settlement on behalf of more than 1,300 plaintiffs in one of the longest-running toxic exposure cases litigated in U.S. courts.
Schlichter Bogard Receives 2026 Top Rankings from Chambers and Partners
Chambers and Partners has once again selected Schlichter Bogard as a leading law firm as the result of its litigation successes on behalf of plaintiffs and its groundbreaking work in retirement litigation.
Schlichter Bogard Featured in St. Louis Post-Dispatch Regarding Upcoming Trial Over Peru Smelter Claims
The St. Louis Post-Dispatch featured Schlichter Bogard in an article concerning an upcoming federal trial involving claims that a Peruvian smelter exposed local residents to toxic substances. The article examines long-running litigation against Doe Run Resources Corp. and its owner, Ira Rennert, in which plaintiffs allege exposure to lead and other hazardous materials from a smelting complex in La Oroya, Peru.
Concert Photos: Taking Back Sunday at the Cleveland House of Blues Was the Reunion Fans Needed
Taking Back Sunday’s return to the Cleveland House of Blues felt like the reunion fans needed. Much like a group of old friends getting back together after a long hiatus, the band shared stories and memories that charted the course to this very night. The evening kicked off with Bayside, a band that brought 20-plus years of punk rock history to the stage. Spanning nine albums, the group in its own right created an atmosphere of reminiscing over the music of our youth.
Illinois Residents Represented by Schlichter Bogard Secure Class Certification in Apple Biometric Privacy Case
As reported by Law360, a U.S. District Judge has certified a class of Illinois residents in a lawsuit alleging that Apple Inc. violated the Illinois Biometric Information Privacy Act (BIPA). The plaintiffs are represented by Schlichter Bogard, which was appointed as class counsel. The case centers on allegations that Apple’s Photos app used facial recognition technology to create biometric “faceprints” of users without obtaining the consent required under BIPA.
Seasoned Litigator Jason Kempf Joins Schlichter Bogard
Schlichter Bogard is pleased to welcome seasoned litigator Jason Kempf to the Firm. For more than two decades, Jason has litigated complex commercial and financial disputes in federal and state courts across the country. He brings extensive experience as first-chair trial counsel in high-stakes securities, financial, and other complex civil matters.
Jerry Schlichter Quoted Regarding Litigation Risks Facing Multiple Employer Plans (MEPs)
Schlichter Bogard Co-Managing Partner Jerry Schlichter was quoted in a Law.com article discussing litigation risks associated with Multiple Employer Plans (MEPs), an increasingly utilized retirement plan structure for unrelated employers. The article examines how the growing use of MEPs—often promoted as cost-efficient retirement solutions for smaller companies—has coincided with class action lawsuits alleging breaches of fiduciary duty.
Jerry Schlichter Interviewed Regarding Private-Market Investments In 401(k) Plans
In an interview with Plan Sponsor Council of America, Schlichter Bogard Co-Managing Partner Jerry Schlichter addressed the growing push to include private‑market investments, including private equity, in employer‑sponsored 401(k) plans.
Schlichter Bogard Files Data Privacy Lawsuits Against Health Insurers Related to Harvesting of Private Health Information
As has been reported, Schlichter Bogard has filed a series of class action lawsuits against major health insurers, alleging that the insurers used concealed tracking tools to capture users’ private health-related information, which was then shared with third parties. The complaints are brought against four insurers: Humana, Cigna, Elevance Health, and Blue Cross Blue Shield of Michigan.
Letter: A Lansdale train ride, a bridge, and a lesson in seeing the child, not the diagnosis
As a parent of a child on the autism spectrum, I’ve come to realize that much of what is generally accepted about autism revolves around textbook expectations and compliance, not the individual. It’s easy, as a parent, to get caught up in the layers of services, therapy, appointments, medications, and support plans. This letter is a personal reminder, to myself and to others, especially during Autism Awareness Month, that those layers do not and should not define our children.
Sulfatase modifying factors control the timing of zebrafish convergence and extension morphogenesis
Abstract Convergence and extension (C&E) cell movements that elongate the primary embryonic axis are precisely timed during vertebrate gastrulation, but mechanisms controlling their onset remain unknown. Using zebrafish embryonic explants that recapitulate C&E and its timing, we identified sulfatase modifying factor 2 (sumf2) as a candidate trigger gene for C&E onset.
Antithrombin-binding heparan sulfate is ubiquitously expressed in epithelial cells and suppresses pancreatic tumorigenesis
Abstract 3-O-sulfation of heparan sulfate (HS) is the key determinant for binding and activation of antithrombin III (AT). This interaction is the basis of heparin treatment to prevent thrombotic events and excess coagulation. Antithrombin-binding HS (HSAT) is expressed in human tissues but is thought to be expressed in the subendothelial space, mast cells, and follicular fluid. Here, we show that HSAT is ubiquitously expressed in the basement membranes of epithelial cells in multiple tissues.
Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis - Nature
Abstract Lipids are essential components of cancer cells due to their structural and signalling roles1. To meet metabolic demands, many cancers take up extracellular lipids2,3,4,5; however, how these lipids contribute to cancer growth and progression remains poorly understood. Here, using functional genetic screens, we identify uptake of lipoproteins—the primary mechanism for lipid transport in circulation—as a key determinant of ferroptosis sensitivity in cancer.
'Bone’s Bazaar Horror Market' brings indie horror and DIY culture to Quakertown on May 17 | NorthPennNow
Fans of horror, independent film, DIY culture, get ready for a blood-curdling experience like no other! On Saturday, May 17, Sinister Bones Events, LLC, the brainchild of indie filmmaker Bone Jawnson, creator of "The Legend of Crick Foot", will debut a thrilling new event, "Bone's Bazaar Horror Market" at the Quakertown Farmers Market.
Hanwha Eagles Re-Sign Ryan Weiss
About 1 minute reading time. On Friday, the Hanwha Eagles announced they had re-signed right-handed starting pitcher Ryan Weiss to a one-year contract. The deal will earn the 28-year-old Weiss $750k in 2025 with incentives worth up to $950k. https://x.com/hoodi_thespace/status/1859819979690111013?s=61&t=uYKsZ7wqUwaDo0ObXNetAQ A 2018 fourth-round pick by the Arizona Diamondbacks, Weiss complied a 4.88 ERA in five years in the Diamondbacks and Royals minor-league systems.
Rite Aid to Close All Remaining Michigan Locations By End of September
All Michigan Rite Aid locations will close by the end of September, the store chain confirmed Wednesday to several media outlets. “We’re disappointed the same way that everybody else is,” said Eric Roath, director of Government Affairs for the Michigan Pharmacists Association.
FTC Releases Interim Staff Report on Prescription Drug Middlemen
The Federal Trade Commission today released a scathing report on how pharmacy benefit managers (PBMs) profit at the expense of patients by inflating drug costs and squeezing independent pharmacies. In the report, the FTC details how vertical integration and concentration has enabled the six largest PBMs to manage nearly 95% of all prescriptions filled in the United States.
How PBMs Are Driving Up Prescription Drug Costs
Americans are paying too much for prescription drugs. It is a common, longstanding complaint. And the culprits seem obvious: Drug companies. Insurers. A dysfunctional federal government. But there is another collection of powerful forces that often escape attention, because they operate in the bowels of the health care system and cloak themselves in such opacity and complexity that many people don’t even realize they exist. They are called pharmacy benefit managers.
Pharmacy Day at the Capitol 2024 Canceled
With the release of the second half of the 2024 legislative session calendar, MPA has made the difficult decision to cancel Pharmacy Day at the Capitol this year as the previously scheduled date (Sept. 10) is not indicated as being a session day. Though this is an unfortunate outcome, we want to make sure that our volunteers have excellent advocacy experiences and that we make the most of their precious time.
APhA and NASPA Release First PWWR Report and Learnings For 2024
The American Pharmacists Association (APhA) and the National Alliance of State Pharmacy Associations (NASPA) have released the ninth installment of the Pharmacy Workplace and Well-being Reporting (PWWR) trends and learnings report series. Launched in October 2021, PWWR serves as a safe space to submit both positive and negative pharmacy workplace experiences in a confidential and anonymous manner.
MPA's Hogue Elected as Chair of ASHP House of Delegates
Congratulations to MPA member Jesse Hogue, who was elected and installed as chair of the American Society of Health-System Pharmacists’ (ASHP) House of Delegates June 11! Hogue’s term as chair will expire in 2027. The chair presides at all meetings of the House of Delegates, is a member of the ASHP Board of Directors and represents the House of Delegates at all Board meetings.
FDA Updates COVID-19 Vaccine Requirements for Fall 2024
The the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee unanimously recommended a monovalent JN.1-lineage vaccine composition for the fall COVID-19 vaccine formula.
Identifying Victims of Human Trafficking
Pharmacy Services Inc. has partnered with the Michigan Pharmacists Association to offer “Identifying Victims of Human Trafficking” as a licensed program to organizations. This program meets Michigan’s requirements defined in MCL 333.16148 that health professionals complete education about identifying victims of human trafficking before licensure or license renewal. This program is available without continuing education credit as an institutional license of the content.
Controlled Substances Inventory Form
Michigan law requires an annual physical inventory of controlled substances to be completed between April 1 and June 30. You do not have to submit the inventory form to the state, but must be able to provide a copy if requested by the state. Be on top of this important task by using the Controlled Substance Inventory List available from Pharmacy Services Inc. Fill out the form below to get started.
Optics in Action: 43
Your host, Ryan Weiss, talks with the Senior Vice President and Managing Partner of Kyndryl, Onofrio Pirrotta. With over two decades in the tech industry, Onofrio's motivation stems from witnessing the tangible changes technology can bring to businesses. He likens his work to that of an architect or a builder, finding immense satisfaction in designing solutions and seeing them come to fruition.
PTPO Program Enrollment Form
For pharmacies wishing to enroll individuals in Pharmacy Tech Prep Online, please fill out the registration form below. Address(Required) Street Address City State ZIP Code Fees(Required) The price to enroll or renew your pharmacy in this program is $49. Price: $49.00 Quantity: Payment Information(Required) American Express Discover MasterCard Visa Card Number Cardholder Name Name This field is for validation purposes and should be left unchanged.
MPA Promotes Jalloul to Chief Pharmacy Officer
The Michigan Pharmacists Association (MPA) proudly announces the promotion of Farah Jalloul to chief pharmacy officer. Jalloul’s exceptional leadership, unwavering dedication and outstanding contributions to the Association have positioned her as the ideal candidate for this pivotal role. During her tenure with MPA, Jalloul has consistently represented the state and the pharmacy profession with professionalism and integrity.
Joint Providership - Co-Presenter/Conflict of Interest
Please complete this faculty agreement and send it to the activity coordinator, along with requested information. Name(Required) First Last Credentials Address(Required) Street Address Address Line 2 City State / Province / Region ZIP / Postal Code Please provide details of the activity. Event Type Time : AM/PM Submit a detailed CV via e-mail and write a short biography below for inclusion in the onsite faculty introduction. Bio should be no longer than 250 words.
Kaski: Incorporate Immunization Status Reports Into Doctor Visits
MPA member Jim Kaski recently had an editorial on immunization status published in the Detroit News. Click here to read Kaski’s piece. NOTE: A Detroit News subscription is required to view the article.
Drug Delays, Skyrocketing Prices an Ongoing Effect of Massive Cyberattack
Frustrated patients in Michigan and around the country have had to pay out of pocket for medicine for chronic diseases and other illnesses or go without in the fallout from a cyberattack of a major health care company. The tech company, Change Healthcare, has restored access to many of its systems in the weeks since the Feb. 21 attack announcement.
Bills to Authorize Pharmacist Hormonal Contraception Prescribing Introduced in House
House Bills (HB) 5435 and 5436, sponsored by Reps. Kara Hope, D-Holt, and Stephanie Young, D-Detroit, were introduced earlier this week in the Michigan House of Representatives. The legislation, as introduced, would allow for pharmacists to issue a prescription for and dispense a hormonal contraceptive patch, self-administered hormonal contraceptive, or vaginal ring hormonal contraceptive to a patient.
FDA Allows Import of French Drug To Combat Bicillin L-A Shortage
To help address the ongoing shortages of Bicillin L-A (penicillin G benzathine injectable suspension), the only drug that can be used to treat congenital syphilis, the U.S. Food and Drug Administration has approved temporary importation of Extencilline (benzathine benzylpenicillin) from French manufacturers Laboratories Delbert and Provepharm. The dosing and pharmacology of Extencilline can be located here. New Jersey-based Direct Success will be the sole U.S. distributor of imported Extencilline.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Ryan
Contact Ryan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack